BONVIVA i.v. sol inj 3 mg/3ml ser pré 3 ml
7680575260011
CH-57526
M05BA06
07.99.0.
Reimbursement limitations:
BONVIVA
Pour le traitement de l'ostéoporose documentée.
1 / 3
google
Details
- Product number
- 5752601
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- acidum ibandronicum 3 mg ut natrii ibandronas monohydricus, natrii chloridum, acidum aceticum glaciale, natrii acetas trihydricus, aqua ad iniectabile ad solutionem pro 3 ml corresp. natrium 10.469 mg.
Articles (1)
Bonviva i.v., Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.469 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 69.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2006
Authorization holder
Atnahs Pharma Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 57526
- Drug name
- Bonviva i.v., Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- M05BA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/06/2006
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BONVIVA i.v. sol inj 3 mg/3ml ser pré 3 ml
- Description (DE)
- BONVIVA i.v. Inj Lös 3 mg/3ml Fertspr 3 ml
- Market launch
- 28/06/2006
- Narcotic (BTM)
- No